Description: Summary of current state of A&H reinsurance business.

Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: Source: This document is a whitepaper sourced from a health insurance industry analysis. It provides a detailed overview of the evolution and strategic importance of voluntary benefits within employer-sponsored health plans in the United States. Intent: The paper aims to inform healthcare stakeholders—particularly employers, insurers, and HR professionals—about the role of voluntary benefits in filling coverage gaps left by major medical plans. It outlines the historical development, market drivers, regulatory context (especially post-ACA), and future trends, with a focus on personalization, digital integration, and financial protection. Value: This resource offers practical insights and strategic guidance for enhancing benefits design and employee engagement.

Description: A listing of publications dealing with health insurance, public pensions and taxes 3 separate abstracts on 3 subjects, not related to each other

Description: Offering supplemental benefits likes accident, hospital indemnity and critical illness to traditional worksite employees has become routine, but how do you handle gig workers? Traditionally these workers would be considered uninsurable, but can you afford to ignore them? The panel will discuss the unique factors of the gig economies and key thoughts for providing insurance in this space.

Description: International case study discussing life insurance in Ghana.

Description: This abstract describes a presentation that presents an overview of the current predictive modeling practices in the auto insurance industry, the challenges telematics presents in the current analytics environment and how the actuaries need to evolve to meet the challenges.

Description: Summary of research from the Initiative 18/11 - Pharmacy team about the drug development process for traditional pharmaceuticals: Who does the research and discovery? What does the research and discovery process entail? How are targets identified and validated for research and discovery? What are clinical trials and how are they conducted? How is the drug development process regulated? How is the drug development process funded?

Description: Stale portfolio got your sales down? In this session, you'll learn about the latest and greatest in product development trends and innovations which you can use to refresh and revitalize your products. At the conclusion of this session, attendees will have a better understanding on market trends in product development as well as leading innovations.